KU-19-19 Cells

KU-19-19 is a human bladder carcinoma cell line established from an adult male patient with metastatic transitional cell carcinoma of the bladder. The cell line exhibits epithelial morphology and grows adherently under standard culture conditions. KU-19-19 has been characterized as a constitutive producer of multiple hematopoietic growth factors, demonstrating robust cytokine secretion activity in vitro. Conditioned medium derived from KU-19-19 cultures strongly stimulates proliferation of growth factor-dependent hematopoietic cell lines, indicating functional secretion of biologically active cytokines.

Biochemical analyses of KU-19-19-conditioned medium have documented high levels of granulocyte colony-stimulating factor (G-CSF), exceeding 5 ng/mL, along with detectable secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), stem cell factor (SCF), interleukin-6 (IL-6), and interleukin-8 (IL-8). Functional proliferation assays using cytokine-dependent leukemia cell lines, including myeloid and megakaryocytic models, have confirmed that KU-19-19-derived factors significantly enhance DNA synthesis as measured by thymidine incorporation. The proliferative response is dose-dependent and observed across a broad panel of hematopoietic cell lines, underscoring the biological potency of secreted factors.

Cytokine production in KU-19-19 cells is modulated by external stimuli. Short-term exposure to phorbol ester (TPA), interleukin-1β, or interferon-γ results in increased secretion of G-CSF, GM-CSF, and M-CSF, demonstrating that multiple regulatory signaling pathways control cytokine expression in this model. These properties make KU-19-19 a valuable in vitro system for studying tumor-derived cytokine production, tumor-hematopoietic cell interactions, and the regulation of growth factor secretion in bladder carcinoma.